HealthEquity, Inc. (NASDAQ:HQY ) Q2 2026 Earnings Call September 2, 2025 4:30 PM EDT Company Participants Richard Putnam - Vice President of Investor Relations Scott Cutler - CEO, President & Direc...

HealthEquity (HQY) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.86 per share a year ago.

HQY remains a buy for long-term investors, with exceptional economics, high margins, and capital-light growth despite recent multiple contraction. Q1 FY26 results showed strong revenue and earnings...

Funding supports 20 nonprofit organizations focused on physical and mental health, financial literacy, and basic needs as the foundation grows and welcomes a new leader Funding supports 20 nonprofi...

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

Investors interested in stocks from the Medical Services sector have probably already heard of Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two companies is the best opti...

HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.

HealthEquity, Inc. (NASDAQ:HQY ) Q1 2026 Earnings Conference Call June 3, 2025 4:30 PM ET Company Participants James M. Lucania - CFO & Executive VP Jon Kessler - Former Director & Special Advisor ...

HealthEquity benefits from secular HSA growth and higher interest rates, with Q1 results beating expectations and guidance raised slightly. The core investment thesis is HQY's earnings power is hig...

HealthEquity (HQY) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.80 per share a year ago.

HQY's sustained strength in HSAs raises optimism about the stock.

Evaluate the expected performance of HealthEquity (HQY) for the quarter ended April 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key met...

NEW YORK CITY, NY / ACCESS Newswire / May 10, 2025 / Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc. ("HealthEquity" or the "Company") (NASDAQ:HQY). Such investor...

NEW YORK CITY, NY / ACCESS Newswire / April 28, 2025 / WHY: New York, N.Y., April 28, 2025.

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, ...